If you have been reading about AOD-9604 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-07-18. Numbers and descriptions here follow the published literature rather than marketing material.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
| Property | Value | Notes |
|---|---|---|
| Common synonym | hGH fragment 176-191 | Refers to the C-terminal segment |
| Appearance | White to off-white powder | Typically supplied lyophilized |
| Solubility | Soluble in water and aqueous buffers | Confirm with technical data |
| Typical storage temperature | -20 °C for dry powder | Protect from moisture and light |
| Common analytical method | RP-HPLC with UV detection | Often paired with mass spectrometry |
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
Proposed mechanism focuses on lipolysis, the breakdown of stored triglycerides into free fatty acids and glycerol. AOD-9604 is thought to act on adipose tissue without stimulating appetite or affecting blood sugar in the same way as growth hormone. Laboratory studies report increased fat oxidation in some models. The precise receptor interactions and signaling pathways remain incompletely characterized. Researchers have proposed that the peptide may influence fat mobilization through pathways distinct from the full hormone.
Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.
A central uncertainty is whether observed metabolic changes translate into meaningful clinical benefits. Study designs vary in dose, duration, and participant characteristics, making comparisons difficult. Independent replication is limited, and the field lacks consensus on optimal endpoints or treatment duration. Ongoing or future studies may clarify mechanism and effect size, but current evidence does not establish a clear therapeutic role. Researchers often call for larger, longer, and better-controlled trials, while questions remain about which patient groups might respond.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
=== Category:EC 4.1 (carbon–carbon lyases) === Category:EC 4.1.1 Ornithine decarboxylase (EC 4.1.1.17) Uridine monophosphate synthetase (EC 4.1.1.23) Aromatic-L-amino-acid decarboxylase (EC 4.1.1.28) RubisCO (EC 4.1.1.39) Category:EC 4.1.2 Fructose-bisphosphate aldolase (EC 4.1.2.13)
==== Impeachment attempt ==== On 20 November 2021, Popular Force, Go on Country, and Popular Renewal backed a motion by Patricia Chirinos to impeach President Castillo for "moral incapacity." With the three parties only having 43 votes out of the 87 needed for impeachment, Popular Renewal parliamentarian José Cueto said that he was aware that the motion would fail, but hoped that the motion would get 52 signatures to allow for Congress to summon President Castillo for questioning before Congress. Free Peru's members initially presented contradictory statements on the impeachment. Meanwhile, Together for Peru denounced the impeachment attempt as a "coup maneuver." On 28 November 2021, Cuarto Poder teased footage of various people entering Castillo's campaign house in Breña. Among these people were Castillo, who entered without his characteristic Chotano hat. As the meetings were unregistered (against Peruvian regulations), many hyped up the Cuarto Poder reports as a prelude to a major corruption expose against Castillo's administration. On 6 December 2021, Free Peru concluded an extraordinary national assembly by announcing that it would vote unanimously against an impeachment. On 1 December 2021, Prime Minister Mirtha Vásquez assured that the Breña house and other places outside the Government Palace will no longer be used for meetings and assured that measures would be taken in order to improve transparency. Vásquez also said Castillo would be willing to be transparent regarding the people he met at the Breña house.
Alamethicin is a channel-forming peptide antibiotic, produced by the fungus Trichoderma viride. It belongs to peptaibol peptides which contain the non-proteinogenic amino acid residue Aib (2-aminoisobutyric acid). This residue strongly induces formation of alpha-helical structure. The peptide sequence is
Traditional approaches in treating patients with DDD-resultant herniated discs oftentimes include discectomy—which, in essence, is a spine-related surgical procedure involving the removal of damaged intervertebral discs (either whole removal, or partially-based). The former of these two discectomy techniques involved in open discectomy is known as Subtotal Discectomy (SD; or, aggressive discectomy) and the latter, Limited Discectomy (LD; or, conservative discectomy). However, with either technique, the probability of post-operative reherniation exists and at a considerably high maximum of 21%, prompting patients to potentially undergo recurrent disk surgery. New treatments are emerging that are still in the beginning clinical trial phases. Glucosamine injections may offer pain relief for some without precluding the use of more aggressive treatment options. Adult stem cell or cell transplantation therapies for disc regeneration are in their infancy of development, but initial clinical trials have shown cell transplantation to be safe and initial observations suggest some beneficial effects for associated pain and disability. An optimal cell type, transplantation method, cell density, carrier, or patient indication remains to be determined. Investigation into mesenchymal stem cell therapy knife-less fusion of vertebrae in the United States began in 2006 and a DiscGenics nucleus pulposus progenitor cell transplantation clinical trial has started as of 2018 in the United States and Japan.
Sources: en.wikipedia.org
Thépegnier thought that the influences on the band's sound in general, and that on 2025's Saddiction, were probably a combination of their aggressive hardcore punk background and a strong interest in UK post-punk, as well as in cold wave and new wave, which produce "cold sounds and textures". A Loner and Saddiction were sonically influenced by post-punk and cold wave. Chanut and Toufouti also cited Chris Cornell and Dax Riggs as musical and artistic inspirations. The group cited the works of authors such as Baudelaire, Camus, and Céline, as well as true crime stories and French magazines such as Le Nouveau Détective (lit. 'The New Detective') and L'Œil de la police (lit. 'The Eye of the Police') among their thematic influences. They also cited Apocalypse Culture as an influence. They drew inspiration from period films, which led to the samples used in their music. The David Lynch-style ambiences and the film Dead Man also inspired their interludes. The French film score composer François de Roubaix was cited by the group as an important source of inspiration. In addition, documentaries such as Black Tar Heroin, Cut Up Kids, [Jon Alpert's] Dope Sick Love, Streetwise and Whores' Glory influenced them.
There, he marveled at the geometric order and vast scale of the Pyramids of the Sun and the Moon, which he believed were constructed in accordance with astronomical observations. Humboldt measured the heights of these pyramids and studied their orientation, considering how the structures would have appeared a thousand years earlier, adorned with gilded images of gods. He was intrigued by the rubble of sun-baked bricks and pottery found within the pyramids, pondering their original purpose and construction techniques. Throughout his travels, Humboldt was deeply interested in the daily lives and cultural practices of Mexico’s indigenous peoples. He frequently inquired about local customs, tools, village names, and natural resources, filling his notebooks with details that even his native guide considered too elementary for a scholar. Receiving news from Berlin, Humboldt decided to postpone his plans for a global voyage due to damaged instruments, logistical difficulties, and the urgent pace of scientific progress in Europe. He resolved to remain in Mexico until spring 1804, making the most of his time by conducting local excursions and research. Humboldt’s scientific rigor was evident in his accurate astronomical and barometric measurements, which closely matched later calculations. In August 1803, he departed on an extensive tour, inspecting the Nochistongo canal, an engineering feat designed to protect Mexico City from floods, and collecting fossil remains for European scientists.
hydraulic skeleto-muscular apparatus of the feathers This functional component consists of the only of the structural features of the feather tracts, namely the cutis, and connective tissue layer fascia superficialis. This functional component was named "hydraulic skeletal" due to the fact that the fat bodies embedded within cutis and fascia act similar to the hydrostatic bodies within a hydrostatic skeleton. However the functional role of the fat bodies within the hydraulic skeleto-muscular apparatus of the feathers is to counteract forces generated by the erector and depressor muscle of the feathers tracts. rather than to facilitate movement within of a body.
Sources: en.wikipedia.org
intensive farming methods requires 214 liters (47 imp gal; 57 U.S. gal) of water; using hydroponics, 70 liters (15 imp gal; 18 U.S. gal); and only 20 liters (4.4 imp gal; 5.3 U.S. gal) using aeroponics. Hydroponic cultures lead to highest biomass and protein production compared to other growth substrates, of plants cultivated in the same environmental conditions and supplied with equal amounts of nutrients. Hydroponics is not only used on earth, but has also proven itself in plant production experiments in Earth orbit.
Fresh parsley is 88% water, 6% carbohydrates, 3% protein, and 1% fat (table). In a reference amount of 100 g (3.5 oz), raw parsley supplies 36 calories and is a rich source (20% or more of the Daily Value, DV) of vitamin K, vitamin C, vitamin A, folate, and iron, with moderate content of other dietary minerals (table). Fresh parsley contains apigenin and myricetin.
Erythema annulare centrifugum (deep gyrate erythema, erythema perstans, palpable migrating erythema, superficial gyrate erythema) Erythema gyratum repens (Gammel's disease) Erythema migrans (erythema chronicum migrans) Erythema multiforme Erythema multiforme minor (herpes simplex-associated erythema multiforme) Erythema palmare Generalized erythema Necrolytic acral erythema Necrolytic migratory erythema (glucagonoma syndrome)
Sources: en.wikipedia.org
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.
No. It is a shortened peptide fragment, not the full hormone. It does not contain the entire hGH sequence and is studied for different proposed effects.
Regulatory approvals for weight loss are not established in major jurisdictions. Some human trials reported modest changes, but the evidence is limited, and it remains a research compound.
No. Major drug regulators have not approved AOD-9604 for weight loss or any other therapeutic indication. It remains an investigational compound studied in research settings.